Xenon Pharmaceuticals Inc (XENE) Financials
Key financial figures for Xenon Pharmaceuticals Inc (Q2 2026).
Xenon Pharmaceuticals Inc. reported revenue of $0.00 for Q2 FY2026. The company posted a net loss of $110.7 million, or -$1.11 per share. Free cash flow for the period was -$95.7 million. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Xenon Pharmaceuticals Inc. are on the SentiSense financials page.
- Revenue
- $0
- Net Income
- -$111M
- EPS
- $-1.11
- Total Assets
- $1.3B
- Operating Cash Flow
- -$95M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $0 | -$111M | -$1.11 | -$96M | |
| Q1 FY2026 | $0 | -$102M | -$1.17 | -$89M | |
| Q4 FY2025 | $0 | -$105M | -$1.31 | -$82M | |
| Q3 FY2025 | $0 | -$91M | -$1.15 | -$72M | |
| Q2 FY2025 | $0 | -$85M | -$1.07 | -$64M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $8M | -$346M | -$4.36 | -4974.27% | -$280M |
| FY2024 | $0 | -$234M | -$3.01 | -$184M | |
| FY2023 | $0 | -$182M | -$2.73 | -$151M |
Frequently asked questions
What was Xenon Pharmaceuticals Inc.'s revenue last quarter?
Xenon Pharmaceuticals Inc. reported revenue of $0.00 for Q2 FY2026.
Is Xenon Pharmaceuticals Inc. profitable?
Not in its most recent reported period. Xenon Pharmaceuticals Inc. reported a net loss of $110.7 million for Q2 FY2026.
When does Xenon Pharmaceuticals Inc. report next?
Xenon Pharmaceuticals Inc. is scheduled to report Q3 2026 results on 2026-11-09. That date is an estimate and has not been confirmed by the company.
Full income statement, balance sheet and cash flow for Xenon Pharmaceuticals Inc on SentiSense, with up to forty quarters and twenty fiscal years of history.